DIABETES Connective Tissue Growth Factor Acts Within Both Endothelial Cells and β Cells to Promote Proliferation of Developing β Cells This study investigated the tissue interactions by which connective tissue growth factor promotes normal pancreatic islet development. [Proc Natl Acad Sci USA] Abstract The Functional Performance of Microencapsulated Human Pancreatic Islet-Derived Precursor Cells Whole human islets were obtained by multi-enzymatic digestion of cadaveric donor pancreases, plated on tissue flasks, and allowed to adhere and expand for several in vitro passages, in order to obtain human islet-derived stem/precursor cells. [Biomaterials] Abstract Transcriptomes of the Major Human Pancreatic Cell Types Investigators sought to determine the messenger RNA transcriptome of all major human pancreatic endocrine and exocrine cell subtypes, including human alpha, beta, duct and acinar cells. In addition, researchers identified the cell type-specific distribution of transcription factors, signaling ligands and their receptors. [Diabetologia] Abstract A Role for the Putative Cannabinoid Receptor GPR55 in the Islets of Langerhans The results reveal the expression of GPR55 receptors in the endocrine pancreas as well as its function at stimulus-secretion coupling of insulin secretion suggesting a role in glucose homeostasis. [J Endocrinol] Abstract Arx and Nkx2.2 Compound Deficiency Redirects Pancreatic Alpha- and Beta-Cell Differentiation to a Somatostatin/Ghrelin Co-Expressing Cell Lineage The data indicates that Nkx2.2 acts by reinforcing the transcriptional networks initiated by Pax4 and Arx in early committed beta- and alpha-cells, respectively. [BMC Dev Biol] Abstract PANCREATIC CANCER Toll-Like Receptor 9 Agonist IMO Cooperates with Cetuximab in K-Ras Mutant Colorectal and Pancreatic Cancers In the present study researchers investigated, both in vitro and in vivo, the antitumor effect of IMO alone or in combination with cetuximab in subcutaneous colon and orthotopic pancreatic cancer models harboring K-Ras mutations and resistant to epidermal growth factor receptor inhibitors. [Clin Cancer Res] Abstract Detection of KRAS Gene Mutations in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for Improving Pancreatic Cancer Diagnosis The study aimed to evaluate the usefulness of a novel method for the detection of mutations in the KRAS (Kirsten rat sarcoma-2 virus) gene for the diagnosis of pancreatic cancer. [Am J Gastroenterol] Abstract 3,5-Bis (2,4-Difluorobenzylidene)-4-Piperidone, a Novel Compound That Affects Pancreatic Cancer Growth and Angiogenesis In this study, scientists have developed a novel compound 3,5-bis (2,4-difluorobenzylidene)-4-piperidone and determined that it inhibits cancer cell growth and its effects on Notch signaling. [Mol Cancer Ther] Abstract Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis and Metastasis by Effects on Tumor Cells, Endothelial Cells and Pericytes in Pancreatic Cancer In this study researchers investigated the effects of TKI258, a tyrosine kinase inhibitor to fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and vascular-endothelial growth factor receptor (VEGFR), on pancreatic cancer cell lines (HPAF-II, BxPC-3, MiaPaCa-2, L3.6pl), endothelial cells and vascular smooth muscle cells. [Mol Cancer Ther] Abstract Inactivation of Mirk/Dyrk1B Kinase Targets Quiescent Pancreatic Cancer Cells Researchers show that a novel small molecule Mirk kinase inhibitor blocked tumor cells from undergoing reversible arrest in a quiescent G0 state and enabled some cells to exit quiescence. [Mol Cancer Ther] Abstract  |